uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted July 23, 2019

FDA Warns Seller of CBD Lotions, Patches, Tinctures and Pet Products

On July 22, 2019, the FDA issued a warning letter to Curaleaf, Inc., following an inspection of the company's website which found the company's products, including its CBD Lotion , CBD Pain-Relief Patch, CBD Tincture and Bido CBD for Pets to be "unapproved new and misbranded" drugs. The FDA noted that CBD cannot be sold as a dietary supplement. It also pointed to statements made about the products on the company's website and social media sites that it has determined are drug claims because they promote the products as preventing or treating diseases.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at